Next Article in Journal
The Timing of Antidepressant Effects: A Comparison of Diverse Pharmacological and Somatic Treatments
Next Article in Special Issue
Structural Examination of 6-Methylsulphonylphenanthro- [9,10-C]-furan-1(3H)-one—A Rofecoxib Degradation Product
Previous Article in Journal
Spironolactone Plus Full-Dose ACE Inhibition in Patients with Idiopathic Membranous Nephropathy and Nephrotic Syndrome: Does It Really Work?
Pharmaceuticals 2010, 3(1), 10-18; doi:10.3390/ph3010010

Notes on Article Versions

NoteDate
article html file updated18 January 2013 01:17 CET
article html file updated21 January 2013 19:08 CET
article html file updated25 January 2013 20:38 CET
article html file updated28 January 2013 18:03 CET
article html file updated5 February 2013 20:26 CET
article html file updated6 February 2013 16:18 CET
article xml file uploaded28 April 2014 10:59 CEST
article html file updated28 April 2014 10:59 CEST
Pharmaceuticals EISSN 1424-8247 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert